These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dystrophic pathology in the intrinsic and extrinsic laryngeal muscles in the mdx mouse. Smythe GM J Otolaryngol Head Neck Surg; 2009 Jun; 38(3):323-36. PubMed ID: 19476764 [TBL] [Abstract][Full Text] [Related]
5. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment. Radley HG; Davies MJ; Grounds MD Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402 [TBL] [Abstract][Full Text] [Related]
6. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Briguet A; Courdier-Fruh I; Foster M; Meier T; Magyar JP Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878 [TBL] [Abstract][Full Text] [Related]
10. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice. Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937 [TBL] [Abstract][Full Text] [Related]
11. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice. Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice. Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529 [TBL] [Abstract][Full Text] [Related]
16. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains. van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942 [TBL] [Abstract][Full Text] [Related]
17. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421 [TBL] [Abstract][Full Text] [Related]
18. Fatty acid profile of skeletal muscle phospholipid is altered in mdx mice and is predictive of disease markers. Tuazon MA; Henderson GC Metabolism; 2012 Jun; 61(6):801-11. PubMed ID: 22209669 [TBL] [Abstract][Full Text] [Related]